Amalgamated Bank Has $871,000 Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Amalgamated Bank reduced its position in shares of CorVel Co. (NASDAQ:CRVL) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,663 shares of the business services provider’s stock after selling 93 shares during the quarter. Amalgamated Bank’s holdings in CorVel were worth $871,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CRVL. GAMMA Investing LLC raised its position in shares of CorVel by 98.0% during the second quarter. GAMMA Investing LLC now owns 97 shares of the business services provider’s stock worth $25,000 after purchasing an additional 48 shares during the period. Blue Trust Inc. increased its stake in CorVel by 435.3% during the 3rd quarter. Blue Trust Inc. now owns 91 shares of the business services provider’s stock valued at $30,000 after purchasing an additional 74 shares in the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new position in CorVel during the third quarter worth $102,000. Benjamin F. Edwards & Company Inc. lifted its stake in shares of CorVel by 130.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 411 shares of the business services provider’s stock valued at $105,000 after buying an additional 233 shares in the last quarter. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of CorVel during the third quarter valued at about $208,000. Institutional investors own 51.36% of the company’s stock.

Insider Transactions at CorVel

In other CorVel news, CFO Brandon O’brien sold 1,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $314.98, for a total value of $314,980.00. Following the completion of the transaction, the chief financial officer now owns 6,502 shares in the company, valued at $2,047,999.96. This represents a 13.33 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director R Judd Jessup sold 2,500 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $311.60, for a total value of $779,000.00. Following the sale, the director now directly owns 40,777 shares of the company’s stock, valued at approximately $12,706,113.20. This represents a 5.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 47.57% of the company’s stock.

CorVel Trading Down 2.5 %

Shares of CorVel stock opened at $346.67 on Friday. The company has a market capitalization of $5.94 billion, a P/E ratio of 73.60 and a beta of 1.10. The stock has a fifty day simple moving average of $317.23 and a 200 day simple moving average of $288.95. CorVel Co. has a 12-month low of $203.90 and a 12-month high of $367.84.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, August 31st.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.